About Ro5
Ro5 is a company based in London (United Kingdom) founded in 2018 by Will Montgomery, Roy Tal, and Zygimantas Jocys was acquired by Juvenescence in April 2025. Ro5 operates in a competitive market with competitors including Helix, Owkin, Formation Bio, Benchling and AbSci, among others.
- Headquarter London, United Kingdom
- Founders Will Montgomery, Roy Tal, Zygimantas Jocys
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Juvenescence
(Apr 01, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ro5
Unlock access to complete
Unlock access to complete
Funding Insights of Ro5
Detailed funding history for Ro5
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ro5
Ro5 has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Juvenescence.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
|
Locked | Locked | Locked |
Investor details for Ro5
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ro5
Investment portfolio details for Ro5
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ro5
Detailed financials for Ro5
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ro5 Comparisons
Peer comparison for Ro5
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ro5
Ro5 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Owkin, Formation Bio, Benchling and AbSci, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
Detailed competitors of Ro5
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ro5
Complete news archive for Ro5
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ro5
Ro5 was founded in 2018.
Ro5 is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Ro5 was founded in 2018 in London, United Kingdom, and operates in the biotechnology sector. An AI-driven platform is offered to support drug development strategies through database management. Features include tools for pharmacological studies, bioactivity analysis, and clinical trial evaluation. Assistance is provided to researchers in streamlining workflows and data handling within the pharmaceutical research domain.
Ro5's top competitors include Owkin, Helix and Formation Bio.
Ro5 has 1 investor. Key investors include Juvenescence.